|
humans |
37 |
|
male |
31 |
|
female |
29 |
|
middle aged |
23 |
|
aged |
19 |
|
adult |
17 |
|
hong kong |
17 |
|
risk factors |
13 |
|
adolescent |
12 |
|
prevalence |
12 |
|
child |
11 |
|
chinese |
11 |
|
hong kong - epidemiology |
11 |
|
questionnaires |
10 |
|
atrial fibrillation |
9 |
|
child, preschool |
9 |
|
case-control studies |
8 |
|
aged, 80 and over |
7 |
|
asian continental ancestry group |
7 |
|
cha2ds2-vasc score |
7 |
|
chads2 score |
7 |
|
china - epidemiology |
7 |
|
depression |
7 |
|
regression analysis |
7 |
|
stroke |
7 |
|
aging - immunology - metabolism |
6 |
|
algorithms |
6 |
|
anti-bacterial agents - pharmacology |
6 |
|
anxiety |
6 |
|
aorta, thoracic - pathology - radiography |
6 |
|
arterial calcification |
6 |
|
arthritis, rheumatoid - complications - immunology - physiopathology |
6 |
|
atherosclerosis - epidemiology - physiopathology - radiography |
6 |
|
biostatistics |
6 |
|
calcinosis - epidemiology - physiopathology - radiography |
6 |
|
cardiovascular diseases - epidemiology - physiopathology - radiography |
6 |
|
cardiovascular system - pathology - physiopathology - radiography |
6 |
|
carotid arteries - pathology - radiography |
6 |
|
carrier state - microbiology |
6 |
|
chi-square distribution |
6 |
|
child day care centers |
6 |
|
china |
6 |
|
cluster analysis |
6 |
|
cohort studies |
6 |
|
confirmatory factor analysis |
6 |
|
coronary artery disease - epidemiology - immunology - physiopathology |
6 |
|
coronary vessels - pathology |
6 |
|
drug resistance |
6 |
|
drug resistance, bacterial |
6 |
|
endothelial progenitor cells |
6 |
|
endothelium, vascular - immunology - pathology |
6 |
|
follow-up studies |
6 |
|
heptavalent pneumococcal conjugate vaccine |
6 |
|
lupus erythematosus, systemic - complications - physiopathology |
6 |
|
mass vaccination |
6 |
|
medical sciences |
6 |
|
mesenchymal stem cells - immunology - pathology |
6 |
|
microbial sensitivity tests |
6 |
|
nasopharynx - microbiology |
6 |
|
pneumococcal infections - microbiology |
6 |
|
pneumococcal vaccines |
6 |
|
proportional hazards models |
6 |
|
prospective studies |
6 |
|
quality of life |
6 |
|
rheumatoid arthritis |
6 |
|
serotyping |
6 |
|
sex factors |
6 |
|
streptococcus pneumoniae |
6 |
|
streptococcus pneumoniae - drug effects - immunology |
6 |
|
systemic lupus erythematosus |
6 |
|
tomography, spiral computed |
6 |
|
treatment outcome |
6 |
|
vaccines, conjugate |
6 |
|
vascular calcification |
6 |
|
biological markers - blood |
5 |
|
body mass index |
5 |
|
epidemiologic methods |
5 |
|
health policy |
5 |
|
incidence |
5 |
|
mental health |
5 |
|
models, statistical |
5 |
|
multilevel modeling |
5 |
|
reproducibility of results |
5 |
|
retrospective studies |
5 |
|
adenoma - complications |
4 |
|
anti-bacterial agents - therapeutic use |
4 |
|
anti-ulcer agents - administration & dosage |
4 |
|
anxiety - epidemiology |
4 |
|
atrial fibrillation and stroke |
4 |
|
attitude |
4 |
|
back-projection method |
4 |
|
bariatric surgery - mortality |
4 |
|
beijing sars |
4 |
|
biomarkers |
4 |
|
cancer |
4 |
|
chest pain - epidemiology - psychology |
4 |
|
clinical competence - standards |
4 |
|
clinical competence/*standards |
4 |
|
colorectal neoplasms - complications |
4 |
|
competing risk |
4 |
|
coronary artery disease - complications |
4 |
|
cost-benefit analysis |
4 |
|
counting process |
4 |
|
cross-sectional studies |
4 |
|
cross-sectional study |
4 |
|
curriculum - standards |
4 |
|
curriculum/ *standards |
4 |
|
depression - epidemiology |
4 |
|
diabetes mellitus, type 2 - prevention & control |
4 |
|
dose-response relationship, drug |
4 |
|
double-blind method |
4 |
|
dyspepsia - diagnosis |
4 |
|
dyspeptic patients |
4 |
|
education, medical, undergraduate - standards |
4 |
|
education, medical, undergraduate/*standards |
4 |
|
empirical endoscopy |
4 |
|
end-stage renal disease |
4 |
|
endoscopy - economics - methods |
4 |
|
equivalence range |
4 |
|
exercise capacity |
4 |
|
faculty, medical |
4 |
|
fatty liver - surgery |
4 |
|
gastric balloon |
4 |
|
gastric bypass - statistics & numerical data |
4 |
|
gastroesophageal reflux - epidemiology - psychology |
4 |
|
gastroplasty - statistics & numerical data |
4 |
|
glioblastoma |
4 |
|
h pylori test-and treat |
4 |
|
health services - utilization |
4 |
|
helicobacter infections - diagnosis |
4 |
|
helicobacter pylori - metabolism |
4 |
|
hemodynamics - physiology |
4 |
|
hydrogen-ion concentration |
4 |
|
infectious disease |
4 |
|
kidney failure, chronic - physiopathology - therapy |
4 |
|
knowledge |
4 |
|
lncrnas |
4 |
|
measurement invariance |
4 |
|
mediator |
4 |
|
mgmt |
4 |
|
mindfulness meditation |
4 |
|
mindfulness training |
4 |
|
obesity - surgery |
4 |
|
oral health-related quality of life |
4 |
|
oxygen consumption - physiology |
4 |
|
patient acceptance of health care |
4 |
|
periodontal disease |
4 |
|
peritoneal dialysis |
4 |
|
physical endurance - physiology |
4 |
|
premature atrial complexes |
4 |
|
primary health care |
4 |
|
primary health care - methods |
4 |
|
problem-based learning - methods |
4 |
|
prognosis |
4 |
|
psychiatric status rating scales |
4 |
|
psychology |
4 |
|
questionnaires - standards |
4 |
|
recurrence - prevention & control |
4 |
|
sensitivity and specificity |
4 |
|
severe acute respiratory syndrome |
4 |
|
severe acute respiratory syndrome (sars) |
4 |
|
stagnation |
4 |
|
survival analysis |
4 |
|
teachers |
4 |
|
time-varying fatality rate |
4 |
|
weight loss - physiology |
4 |
|
2-pyridinylmethylsulfinylbenzimidazoles |
3 |
|
absenteeism |
3 |
|
activities of daily living |
3 |
|
adaptation, psychological |
3 |
|
adolescents |
3 |
|
age factors |
3 |
|
amiodarone |
3 |
|
amiodarone - therapeutic use |
3 |
|
anal canal - physiopathology |
3 |
|
anorectal physiology |
3 |
|
anti-arrhythmia agents - therapeutic use |
3 |
|
antibiotic resistance |
3 |
|
antibiotics |
3 |
|
antibodies, antinuclear - blood |
3 |
|
anxiety - complications |
3 |
|
anxiety disorders - ethnology |
3 |
|
arteries - physiopathology |
3 |
|
aspirin |
3 |
|
aspirin - adverse effects |
3 |
|
aspirin - therapeutic use |
3 |
|
atherosclerosis - etiology - physiopathology |
3 |
|
atrial fibrillation - complications - drug therapy - physiopathology |
3 |
|
attitudes |
3 |
|
auxiliary information |
3 |
|
barriers |
3 |
|
bayes theorem |
3 |
|
bayesian approach |
3 |
|
behavior |
3 |
|
behaviour |
3 |
|
biometry - methods |
3 |
|
brownian motion |
3 |
|
cariostatic agents - administration & dosage |
3 |
|
chest pain |
3 |
|
chest pain - diagnosis - etiology - psychology |
3 |
|
chest pain - epidemiology |
3 |
|
child perception questionnaires |
3 |
|
children |
3 |
|
china - ethnology |
3 |
|
chronic disease |
3 |
|
clinical trials as topic - methods |
3 |
|
close friends |
3 |
|
clustered grouped survival data |
3 |
|
colonic diseases, functional - ethnology - psychology |
3 |
|
colorectal neoplasms - etiology |
3 |
|
concomitant variable |
3 |
|
constipation |
3 |
|
constipation - complications |
3 |
|
constipation - diagnosis |
3 |
|
constipation - epidemiology - genetics |
3 |
|
constipation - epidemiology - physiopathology - psychology |
3 |
|
controlled clinical trials as topic - methods |
3 |
|
coping mechanism |
3 |
|
coping strategies |
3 |
|
coronary angiography |
3 |
|
covid-19 |
3 |
|
cox regression |
3 |
|
cpg islands - genetics |
3 |
|
cross-over studies |
3 |
|
data interpretation, statistical |
3 |
|
dementia |
3 |
|
dental care for children - psychology - statistics & numerical data |
3 |
|
dental caries - prevention and control |
3 |
|
dental caries - therapy |
3 |
|
dental cavity preparation |
3 |
|
dental health surveys |
3 |
|
dental health surveys - standards |
3 |
|
dental public health |
3 |
|
dental restoration failure |
3 |
|
dental restoration, permanent |
3 |
|
dentin |
3 |
|
dentistry |
3 |
|
depressive disorder - complications |
3 |
|
depressive disorder - ethnology |
3 |
|
diagnosis |
3 |
|
digoxin |
3 |
|
digoxin - therapeutic use |
3 |
|
diltiazem |
3 |
|
diltiazem - therapeutic use |
3 |
|
disease burden |
3 |
|
disease outbreaks |
3 |
|
disease outbreaks - statistics & numerical data |
3 |
|
disease progression |
3 |
|
dmf index |
3 |
|
domestic violence |
3 |
|
dyspepsia |
3 |
|
dyspepsia - ethnology - psychology |
3 |
|
dyspepsia - physiopathology |
3 |
|
dyspnea - epidemiology |
3 |
|
e-learning |
3 |
|
efficiency |
3 |
|
enablers |
3 |
|
environmental monitoring - statistics & numerical data |
3 |
|
epidemiology |
3 |
|
face-to-face learning |
3 |
|
facilitators |
3 |
|
fatality rate |
3 |
|
fluorides, topical - administration & dosage |
3 |
|
focus groups |
3 |
|
forecasting |
3 |
|
gastric acidity determination |
3 |
|
gastroesophageal reflux - diagnosis |
3 |
|
gastroesophageal reflux - diagnosis - physiopathology - psychology |
3 |
|
gastroesophageal reflux - drug therapy - ethnology |
3 |
|
gastroesophageal reflux - epidemiology |
3 |
|
gastroesophageal reflux - epidemiology - therapy |
3 |
|
gastroesophageal reflux - ethnology - etiology |
3 |
|
gastroesophageal reflux disease |
3 |
|
gastrointestinal bleeding |
3 |
|
gastrointestinal transit |
3 |
|
genetic predisposition to disease |
3 |
|
geriatric assessment - statistics & numerical data |
3 |
|
glucocorticoids - administration & dosage |
3 |
|
graded response model |
3 |
|
health status |
3 |
|
health surveys |
3 |
|
health systems |
3 |
|
heart failure - epidemiology |
3 |
|
helicobacter infections - complications |
3 |
|
helicobacter pylori |
3 |
|
help-seeking willingness |
3 |
|
hong kong chinese |
3 |
|
hospitalisation |
3 |
|
hospitalization - statistics & numerical data |
3 |
|
hygiene practices |
3 |
|
immigrant |
3 |
|
immunosuppressive agents - administration & dosage |
3 |
|
infectious diseases |
3 |
|
influenza |
3 |
|
influenza, human - epidemiology |
3 |
|
infusions, intravenous |
3 |
|
interleukin-1beta - genetics |
3 |
|
interleukin-33 |
3 |
|
interleukins - blood |
3 |
|
internet use |
3 |
|
interpersonal relations |
3 |
|
irritable bowel syndrome - ethnology - etiology |
3 |
|
item response theory |
3 |
|
kernel method |
3 |
|
length of stay |
3 |
|
likelihood ratio test |
3 |
|
logistic models |
3 |
|
longitudinal invariance |
3 |
|
lupus erythematosus, systemic - drug therapy - immunology |
3 |
|
markov chains |
3 |
|
mds-hc |
3 |
|
monte carlo method |
3 |
|
morbidity |
3 |
|
mouth diseases - epidemiology - physiopathology - psychology |
3 |
|
multilevel modelling |
3 |
|
multinomial model |
3 |
|
needs assessment |
3 |
|
noncardiac chest pain |
3 |
|
odds ratio |
3 |
|
omeprazole - administration & dosage - analogs & derivatives |
3 |
|
online teaching |
3 |
|
open suicide discussion |
3 |
|
oral health |
3 |
|
oral-health-related quality of life |
3 |
|
outcome assessment (health care) - methods |
3 |
|
paired samples |
3 |
|
patient acceptance of health care - ethnology - psychology |
3 |
|
patient acceptance of health care - statistics & numerical data |
3 |
|
perception |
3 |
|
pharmacoepidemiology |
3 |
|
platelet aggregation inhibitors - therapeutic use |
3 |
|
pneumonia - epidemiology |
3 |
|
power |
3 |
|
prednisolone - administration & dosage |
3 |
|
preferred contexts |
3 |
|
primary care physicians |
3 |
|
private online expression |
3 |
|
psoriasis - complications - physiopathology |
3 |
|
psychometrics |
3 |
|
public toilet |
3 |
|
pulmonary disease, chronic obstructive - epidemiology |
3 |
|
quaternary ammonium compounds - administration & dosage |
3 |
|
quaternary ammonium compounds - therapeutic use |
3 |
|
randomized controlled experiment |
3 |
|
ranked set sampling |
3 |
|
ratio estimator |
3 |
|
real-time fatality rate |
3 |
|
receptors, cell surface - blood |
3 |
|
rectum - physiopathology |
3 |
|
recurrent events |
3 |
|
regression estimator |
3 |
|
respiratory diseases |
3 |
|
review |
3 |
|
risk assessment |
3 |
|
seasonal influenza |
3 |
|
seasons |
3 |
|
self-assessment |
3 |
|
severe acute respiratory syndrome - mortality |
3 |
|
severity of illness index |
3 |
|
sick leave |
3 |
|
sick leave - statistics & numerical data |
3 |
|
sickness impact profile |
3 |
|
social behavior |
3 |
|
sodium fluoride - administration & dosage |
3 |
|
software |
3 |
|
soluble st2 |
3 |
|
stomach neoplasms - etiology |
3 |
|
stress, psychological - epidemiology - physiopathology |
3 |
|
structural equation modeling |
3 |
|
suicide |
3 |
|
survey |
3 |
|
survival data |
3 |
|
symptom score |
3 |
|
symptoms |
3 |
|
systemic lupus erythematosus disease activity index |
3 |
|
t helper 2 immune response |
3 |
|
tachycardia, ventricular - etiology - prevention & control |
3 |
|
teaching effectiveness |
3 |
|
ticlopidine - analogs & derivatives - therapeutic use |
3 |
|
time factors |
3 |
|
time-varying regression coefficients |
3 |
|
tooth diseases - epidemiology - physiopathology - psychology |
3 |
|
toothache - epidemiology - physiopathology - psychology |
3 |
|
type i error |
3 |
|
vaccination rate |
3 |
|
validation |
3 |
|
vascular resistance |
3 |
|
ventricular rate control |
3 |
|
winbugs |
3 |
|
world health organization |
3 |
|
youth |
3 |
|
youths |
3 |
|
youths’ attitudes |
3 |
|
zero-mean martingale |
3 |
|
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage |
2 |
|
absorptiometry, photon - methods |
2 |
|
acute coronary syndrome - complications - drug therapy |
2 |
|
acute coronary syndrome - drug therapy |
2 |
|
age of onset |
2 |
|
alternative medicine |
2 |
|
andersen–gill model |
2 |
|
anti-inflammatory agents, non-steroidal - adverse effects |
2 |
|
anti-retroviral agents - therapeutic use |
2 |
|
anti-ulcer agents - administration & dosage - therapeutic use |
2 |
|
antibiotic use |
2 |
|
antibiotics overuse |
2 |
|
antibodies, monoclonal - therapeutic use |
2 |
|
anticoagulants - adverse effects |
2 |
|
asian men |
2 |
|
aspirin - administration & dosage - adverse effects |
2 |
|
aspirin - adverse effects - therapeutic use |
2 |
|
asymptotically efficient |
2 |
|
attitude of health personnel |
2 |
|
automatic boundary correction |
2 |
|
blood coagulation - drug effects |
2 |
|
body weight - physiology |
2 |
|
bone density |
2 |
|
boundary effects |
2 |
|
bunion |
2 |
|
calcifediol - blood |
2 |
|
censoring |
2 |
|
change point |
2 |
|
choice behavior |
2 |
|
clinical competence |
2 |
|
clopidogrel |
2 |
|
community psychiatry - education |
2 |
|
comorbidity |
2 |
|
competing risks |
2 |
|
comprehensive social security assistance (cssa) system |
2 |
|
computer simulation |
2 |
|
constipation - epidemiology - etiology - physiopathology |
2 |
|
continuing medical education |
2 |
|
continuity of care |
2 |
|
coronary angiography - methods |
2 |
|
coronary artery disease |
2 |
|
coronary artery disease - epidemiology - prevention & control |
2 |
|
coronary disease - drug therapy |
2 |
|
coronary disease - etiology - therapy |
2 |
|
coronary restenosis - prevention & control |
2 |
|
counting processes |
2 |
|
covariates |
2 |
|
cumulative incidence function |
2 |
|
cured proportion |
2 |
|
curriculum |
2 |
|
decision making |
2 |
|
decomposition analysis |
2 |
|
demographics |
2 |
|
depression - physiopathology - therapy |
2 |
|
depressive disorder - psychology - therapy |
2 |
|
derivative estimation |
2 |
|
dermatology |
2 |
|
diabetes mellitus, type 2 - complications |
2 |
|
doctors' perceptions |
2 |
|
drug prescriptions |
2 |
|
drug therapy, combination |
2 |
|
drug utilization - statistics & numerical data |
2 |
|
dynamic random effects |
2 |
|
education, medical, graduate |
2 |
|
educational measurement |
2 |
|
effective kernel |
2 |
|
effectiveness |
2 |
|
efficient estimation |
2 |
|
em algorithm |
2 |
|
empathy |
2 |
|
enoxaparin - administration & dosage - adverse effects |
2 |
|
enoxaparin - adverse effects |
2 |
|
equivalent kernel |
2 |
|
esophagus - physiology |
2 |
|
essential medicines policy |
2 |
|
estimating equation |
2 |
|
estradiol - blood |
2 |
|
expected urti duration |
2 |
|
factor analysis |
2 |
|
factor score |
2 |
|
failure time |
2 |
|
failure time data analysis. |
2 |
|
family |
2 |
|
family medicine |
2 |
|
family physician |
2 |
|
family physicians |
2 |
|
family practice |
2 |
|
family practice - education |
2 |
|
family practice - standards |
2 |
|
famotidine - administration & dosage |
2 |
|
famotidine - administration & dosage - therapeutic use |
2 |
|
ferritin |
2 |
|
fibrinolytic agents - administration & dosage - adverse effects |
2 |
|
first-contact care |
2 |
|
focus group |
2 |
|
fractures, bone - epidemiology - physiopathology |
2 |
|
frequent attendance |
2 |
|
gastroesophageal reflux - ethnology - physiopathology |
2 |
|
gastrointestinal hemorrhage - chemically induced |
2 |
|
gastrointestinal hemorrhage - chemically induced - epidemiology - physiopathology |
2 |
|
gastrointestinal hemorrhage - chemically induced - epidemiology - prevention & control |
2 |
|
gastrointestinal hemorrhage - chemically induced - prevention & control |
2 |
|
general practice |
2 |
|
general practitioners |
2 |
|
general public |
2 |
|
geriatrics - education |
2 |
|
gestational diabetes |
2 |
|
gibbs sampler |
2 |
|
guideline adherence |
2 |
|
hazard rate |
2 |
|
health care reform |
2 |
|
health care surveys |
2 |
|
health care system |
2 |
|
health care utilization |
2 |
|
health knowledge, attitudes, practice |
2 |
|
health professionals |
2 |
|
health reforms |
2 |
|
health service utilization |
2 |
|
health services |
2 |
|
health services misuse - statistics & numerical data |
2 |
|
helicobacter infections - drug therapy - epidemiology |
2 |
|
help seeking |
2 |
|
help-seeking |
2 |
|
hip bmd |
2 |
|
histamine h2 antagonists - administration & dosage |
2 |
|
hiv |
2 |
|
hiv - growth & development |
2 |
|
hiv infections - drug therapy - virology |
2 |
|
hormones |
2 |
|
hypertension - complications |
2 |
|
immunoglobulin fab fragments - therapeutic use |
2 |
|
impaired glucose tolerance |
2 |
|
infant |
2 |
|
infant, newborn |
2 |
|
informative cluster size |
2 |
|
intensity function |
2 |
|
interval-censored data |
2 |
|
intestinal perforation - etiology - prevention & control |
2 |
|
iron supplement |
2 |
|
ischemic heart disease |
2 |
|
iv infusion |
2 |
|
kap |
2 |
|
kernel smoothing |
2 |
|
learning outcomes |
2 |
|
learning outcomes of a geriatric course |
2 |
|
life style |
2 |
|
likelihood functions |
2 |
|
local polynomial |
2 |
|
low-trauma fracture |
2 |
|
management |
2 |
|
manometry |
2 |
|
markov chain |
2 |
|
martingale |
2 |
|
martingale estimating equation |
2 |
|
martingales |
2 |
|
medical history taking |
2 |
|
medicine, chinese traditional - psychology - standards |
2 |
|
mental disorders |
2 |
|
mental disorders - diagnosis - therapy |
2 |
|
metatarsus primus varus |
2 |
|
migration |
2 |
|
mixture models |
2 |
|
models, biological |
2 |
|
monte carlo expectation- maximization algorithm |
2 |
|
multiple imputation |
2 |
|
multiple imputations |
2 |
|
multiplicative intensity model |
2 |
|
multivariate analysis |
2 |
|
myocardial ischemia - drug therapy |
2 |
|
nelson-aalen estimator of cumulative hazard |
2 |
|
netherlands |
2 |
|
non-parametric estimation |
2 |
|
non-parametric procedure |
2 |
|
nonparametric estimation |
2 |
|
obstacles |
2 |
|
occupation |
2 |
|
omeprazole - administration & dosage - therapeutic use |
2 |
|
ordered alternatives |
2 |
|
parathyroid hormone - blood |
2 |
|
partial linear model |
2 |
|
partial observation |
2 |
|
patient choice |
2 |
|
patient preference - psychology |
2 |
|
patients - psychology |
2 |
|
patients' expectations |
2 |
|
peptic ulcer |
2 |
|
peptic ulcer - chemically induced - epidemiology - prevention & control |
2 |
|
peptic ulcer - complications |
2 |
|
physician's practice patterns |
2 |
|
physician-patient relations |
2 |
|
physicians |
2 |
|
physicians, family |
2 |
|
physicians, family - education |
2 |
|
physicians, family - education - psychology |
2 |
|
physicians, primary care |
2 |
|
physicians, primary care - education |
2 |
|
pilot projects |
2 |
|
platelet aggregation inhibitors - administration & dosage - adverse effects |
2 |
|
platelet aggregation inhibitors - adverse effects |
2 |
|
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors |
2 |
|
postgraduate training |
2 |
|
poverty rate |
2 |
|
precipitating factors |
2 |
|
predictive value of tests |
2 |
|
pregnancy |
2 |
|
primary care |
2 |
|
primary care doctors |
2 |
|
primary care physician |
2 |
|
private/public |
2 |
|
professional practice - standards |
2 |
|
professional role |
2 |
|
profit-making orientation |
2 |
|
psychiatrists |
2 |
|
psychiatry - education |
2 |
|
psychological distress |
2 |
|
public health |
2 |
|
public opinion |
2 |
|
qualitative research |
2 |
|
quality of health care |
2 |
|
ranked data |
2 |
|
referral |
2 |
|
referral and consultation |
2 |
|
regular doctors |
2 |
|
respiratory tract infection |
2 |
|
respiratory tract infections - drug therapy |
2 |
|
respiratory tract infections - therapy |
2 |
|
return rate |
2 |
|
schizophrenia |
2 |
|
seismology |
2 |
|
self care |
2 |
|
service users |
2 |
|
service utilization |
2 |
|
sichuan earthquake |
2 |
|
sieve maximum likelihood estimator |
2 |
|
social security |
2 |
|
social security system |
2 |
|
socioeconomic status |
2 |
|
statistics, nonparametric |
2 |
|
stents |
2 |
|
stomach - physiology |
2 |
|
suicide cases |
2 |
|
survival analysis (biometry) |
2 |
|
testosterone - blood |
2 |
|
ticlopidine - administration & dosage - adverse effects - analogs & derivatives |
2 |
|
ticlopidine - adverse effects - analogs & derivatives |
2 |
|
traditional chinese medicine |
2 |
|
traditional chinese medicine practitioners |
2 |
|
viral load |
2 |
|
western medicine |
2 |
|
youth mobility |
2 |
|
3 |
1 |
|
acute coronary syndrome - blood - drug therapy |
1 |
|
additive rate model |
1 |
|
anti-ulcer agents - administration and dosage |
1 |
|
antibody titers |
1 |
|
asymptotic normal data augmentation |
1 |
|
asymptotic properties |
1 |
|
asymptotically efficient estimator |
1 |
|
bias reduction |
1 |
|
biomedical research - statistics & numerical data |
1 |
|
body height |
1 |
|
breast cancer |
1 |
|
change-points |
1 |
|
change‐point model |
1 |
|
chi-bar-squared distribution |
1 |
|
child development |
1 |
|
child health |
1 |
|
clinical trials |
1 |
|
clustered interval-censored data |
1 |
|
cognition |
1 |
|
competing risks model |
1 |
|
compound distribution |
1 |
|
compound poisson distribution |
1 |
|
concurrent design |
1 |
|
conditional heterogeneity |
1 |
|
covariate adjustment |
1 |
|
cox regression model |
1 |
|
cure model |
1 |
|
current status data |
1 |
|
degeneration |
1 |
|
delta method |
1 |
|
dental study |
1 |
|
dependent failure times |
1 |
|
diabetic retinopathy |
1 |
|
dichotomization |
1 |
|
disease-free survival |
1 |
|
distal lateral soft tissue release |
1 |
|
distal metatarsal articular angle |
1 |
|
distributional approach |
1 |
|
diverse student background |
1 |
|
dmft |
1 |
|
effectiveness of e-learning |
1 |
|
estimating equations |
1 |
|
event dependence |
1 |
|
famotidine - administration and dosage |
1 |
|
fold increase |
1 |
|
fold-increase |
1 |
|
frailty |
1 |
|
frailty mixture model |
1 |
|
frailty model |
1 |
|
gambia - epidemiology |
1 |
|
generalized linear models |
1 |
|
generalized partly linear model |
1 |
|
ghana |
1 |
|
ghk simulator |
1 |
|
growth |
1 |
|
hallux valgus |
1 |
|
hazard ratio |
1 |
|
importance sampling |
1 |
|
incidence density sampling |
1 |
|
incidence rate |
1 |
|
incidence rate difference |
1 |
|
interval censored |
1 |
|
interval-censored |
1 |
|
interval-censoring |
1 |
|
intervention effects |
1 |
|
intra-cluster correlation |
1 |
|
intracluster correlation |
1 |
|
laplace transform |
1 |
|
learning analytics |
1 |
|
least-squares analysis |
1 |
|
likelihood ratio tests |
1 |
|
linear independence |
1 |
|
linear mixed-effects model |
1 |
|
linear rank statistic |
1 |
|
load sharing |
1 |
|
locally most powerful rank test |
1 |
|
logistic regression |
1 |
|
malaria |
1 |
|
marginal likelihood |
1 |
|
matched case–control study |
1 |
|
maximum likelihood estimator |
1 |
|
mechanical function |
1 |
|
metatarsal callus |
1 |
|
metatarsus adductus |
1 |
|
mixing distribution |
1 |
|
mixture model |
1 |
|
multiplicative rate model |
1 |
|
negative definiteness |
1 |
|
non-linear function |
1 |
|
omeprazole - administration and dosage |
1 |
|
online calculus platform |
1 |
|
optimal convergence rate |
1 |
|
ordered random variables |
1 |
|
osteodesis procedure |
1 |
|
paired interval-censored data |
1 |
|
partly linear model |
1 |
|
plantar calluses |
1 |
|
platelet aggregation inhibitors - administration and dosage |
1 |
|
poisson |
1 |
|
proportional hazards model |
1 |
|
proportional intensity |
1 |
|
proportional odds model |
1 |
|
protective efficacy |
1 |
|
random effect model |
1 |
|
random effects |
1 |
|
rank invariant transformation |
1 |
|
recurrence |
1 |
|
residual maximum likelihood |
1 |
|
right-censored data |
1 |
|
risk ratio |
1 |
|
sample size estimation |
1 |
|
score test |
1 |
|
semiparametric proportional odds model |
1 |
|
sequential analysis |
1 |
|
shared random effect |
1 |
|
sieve estimation |
1 |
|
standard error |
1 |
|
standard titer |
1 |
|
statistical models |
1 |
|
strongly consistent |
1 |
|
stunting |
1 |
|
syndesmosis procedure |
1 |
|
time-varying covariate effects |
1 |
|
time-varying effect |
1 |
|
vaccination - statistics & numerical data |
1 |
|
vaccine |
1 |
|
vaccine efficacy |
1 |
|
waning efficacy |
1 |
|
zero mean martingale |
1 |
|
zero-inflated count data |
1 |
|
zero-inflated poisson regression model |
1 |
